BTMD - biote Corp.
1.32
-0.030 -2.273%
Share volume: 265,480
Last Updated: 03-27-2026
Pharmaceutical Products/Medicinal Chemicals:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$1.35
-0.03
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-12-2024 | 03-14-2025 | 05-09-2025 | 11-07-2025 | 03-13-2026 | |
| Total revenue | 46.804 M | 49.169 M | 51.384 M | 49.834 M | 48.992 M | 47.956 M | 46.408 M | |
| Cost of revenue | 13.367 M | 15.287 M | 15.172 M | 14.304 M | 12.610 M | 13.538 M | 14.835 M | |
| Gross profit | 33.437 M | 33.882 M | 36.212 M | 35.530 M | 36.382 M | 34.418 M | 31.573 M | |
| 1.33% | 6.88% | -1.88% | 2.40% | -5.40% | -8.27% | |||
| Operating expenses | 23.010 M | 27.649 M | 24.028 M | 32.763 M | 26.692 M | 26.151 M | 24.744 M | |
| Selling general and admin | 23.010 M | 27.649 M | 24.028 M | 32.763 M | 26.692 M | 26.151 M | 24.744 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 23.010 M | 27.649 M | 24.028 M | 32.763 M | 26.692 M | 26.151 M | 24.744 M | |
| 20.16% | -13.10% | 36.35% | -18.53% | -2.03% | -5.38% | |||
| Operating income | 10.427 M | 6.233 M | 12.184 M | 2.767 M | 9.690 M | 8.267 M | 6.829 M | |
| Ebit | -1.664 M | -7.718 M | 19.397 M | 2.002 M | 20.360 M | 11.184 M | 8.074 M | |
| Pretax income | -3.324 M | -10.295 M | 15.855 M | -1.220 M | 17.455 M | 8.451 M | 5.603 M | |
| 209.72% | -254.01% | -107.69% | -1,530.74% | -51.58% | -33.70% | |||
| Income tax | 2.486 M | 180.000 K | 3.198 M | -4.894 M | 1.616 M | -765.000 K | 2.986 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.810 M | -10.475 M | 12.657 M | 3.674 M | 15.839 M | 9.216 M | 2.617 M | |
| -80.29% | 220.83% | -70.97% | 331.11% | -41.81% | -71.60% |